The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Vasoactive intestinal peptide: cardiovascular effects
Abstract
Vasoactive intestinal peptide (VIP) is present in the peripheral and the central nervous systems where it functions as a nonadrenergic, noncholinergic neurotransmitter or neuromodulator. Significant concentrations of VIP are present in the gastrointestinal tract, heart, lungs, thyroid, kidney, urinary bladder, genital organs and the brain. On a molar basis, VIP is 50-100 times more potent than acetylcholine as a vasodilator. VIP release in the body is stimulated by high frequency (10-20 Hz) nerve stimulation and by cholinergic agonists, serotonin, dopaminergic agonists, prostaglandins (PGE, PGD), and nerve growth factor. The VIP peptide combines with its receptor and dose-dependently activates adenylyl cyclase. The vasodilatory effect of VIP in different vascular tissues or species also may be due to increases in nitric oxide, cyclic GMP, and other signaling agents. In the heart, VIP immunoreactive nerve fibers are present not only in the epicardial coronary arteries and veins, but also the sinoatrial node, atrium, interatrial septum, atrioventricular node, intracardiac ganglia, and ventricles (right ventricle >> left ventricle). In the coronary arterial walls, VIP may contribute to the regulation of normal coronary vasomotor tone. In research animals and in humans, VIP, administered into the coronary artery or intravenously, increases the epicardial coronary artery cross-sectional area, decreases coronary vascular resistance, and significantly increases coronary artery blood flow. High frequency parasympathetic (vagal) nerve stimulation also releases endogenous VIP in the coronary vessels and heart and significantly increases coronary artery blood flow. In addition, the release of VIP in the heart is increased during coronary artery occlusion and during reperfusion where VIP may promote local blood flow and may have a free-radical scavenging effect. VIP also has a primary positive inotropic effect on cardiac muscle that is enhanced by its ability to facilitate ventricular-vascular coupling by reducing mean arterial pressure by 10-15%. In concentrations of 10(-8)-10(-5) mol, VIP augments developed isometric force and increases atrial and ventricular contractility. The presence of VIP-immunoreactive nerve fibers in and around the sinus and the atrioventricular nodes of mammals strongly suggests that this peptide can affect the heart rate. In this regard, endogenously released or exogenous VIP can significantly increase the heart rate and has a more potent effect on heart rate than does norepinephrine. The presence and significant cardiovascular effects of VIP in the heart suggests that this peptide is important in the regulation of coronary blood flow, cardiac contraction, and heart rate. Current investigations are defining the physiological role of VIP in the regulation of cardiovascular function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polypeptide with Broad Biological Activity: Isolation from Small Intestine
Said, S. I., & Mutt, V. (1970) · Science · doi:10.1126/science.169.3951.1217 · Cited by 1,596
Hyperpolarizing Vasodilators Activate ATP-sensitive K + Channels in Arterial Smooth Muscle
Standen, N. B., Quayle, J. M., Davies, N. W., Brayden, J. E., Huang, Y., & Nelson, M. T. (1989) · Science · doi:10.1126/science.2501869 · Cited by 1,190
Harmar, A. J., Arimura, A., Gozes, I., Journot, L., Laburthe, M., Pisegna, J. R., Rawlings, S. R., Robberecht, P., Said, S. I., Sreedharan, S. P., et al. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01360-7 · Cited by 765
Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons.
Larsson, L. I., Fahrenkrug, J., Schaffalitzky De Muckadell, O., Sundler, F., Håkanson, R., & Rehfeld, J. R. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3197 · Cited by 616
Lundberg, J. M., Änggärd, A., Fahrenkrug, J., Hökfelt, T., & Mutt, V. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1651 · Cited by 481
Said, S. I., & Rosenberg, R. N. (1976) · Science · doi:10.1126/science.1273576 · Cited by 472
Usdin, T. B. (1994) · Endocrinology · doi:10.1210/en.135.6.2662 · Cited by 427
Mutt, V., & Said, S. I. (1974) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1974.tb03373.x · Cited by 414
Edvinsson, L., Fredholm, B. B., Hamel, E., Jansen, I., & Verrecchia, C. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90166-1 · Cited by 372
Vasoactive Intestinal Polypeptide: Measurement, Distribution and Putative Neurotransmitter Function
Fahrenkrug, J. (1979) · Digestion · doi:10.1159/000198339 · Cited by 340
Cited by
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Reubi, J. C. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0007 · Cited by 1,131
The Glymphatic System: A Novel Component of Fundamental Neurobiology
Hablitz, L. M., & Nedergaard, M. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.0619-21.2021 · Cited by 453
Cutaneous Vasodilator and Vasoconstrictor Mechanisms in Temperature Regulation
Johnson, J. M., Minson, C. T., & Kellogg, D. L. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130015 · Cited by 414
The Significance of Vasoactive Intestinal Peptide in Immunomodulation
Delgado, M., Pozo, D., & Ganea, D. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.7 · Cited by 412
Premchand, R. K., Sharma, K., Mittal, S., Monteiro, R., Dixit, S., Libbus, I., DiCarlo, L. A., Ardell, J. L., Rector, T. S., Amurthur, B., et al. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.08.009 · Cited by 377
Metadata
- Authors
- Henning, R.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-01
- Volume
- 49
- Issue
- 1
- Pages
- 27-37
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2161864804
- Cited by
- 280
- References
- 48
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vasoactive intestinal peptide: cardiovascular effects. https://app.cochat.ai/papers/10.1016/s0008-6363(00)00229-7
- The paper
- Henning, R. (2001). Vasoactive intestinal peptide: cardiovascular effects. Cardiovascular Research. https://doi.org/10.1016/s0008-6363(00)00229-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.